176 related articles for article (PubMed ID: 35934721)
1. Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?
Galati F; Rizzo V; Moffa G; Caramanico C; Kripa E; Cerbelli B; D'Amati G; Pediconi F
Eur Radiol Exp; 2022 Aug; 6(1):39. PubMed ID: 35934721
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric MRI Features of Breast Cancer Molecular Subtypes.
Szep M; Pintican R; Boca B; Perja A; Duma M; Feier D; Fetica B; Eniu D; Dudea SM; Chiorean A
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556918
[TBL] [Abstract][Full Text] [Related]
3. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
4. Correlation between the CEM imaging characteristics and different molecular subtypes of breast cancer.
Li N; Gong W; Xie Y; Sheng L
Breast; 2023 Dec; 72():103595. PubMed ID: 37925875
[TBL] [Abstract][Full Text] [Related]
5. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
[TBL] [Abstract][Full Text] [Related]
6. Agreement between MRI and pathologic analyses for determination of tumor size and correlation with immunohistochemical factors of invasive breast carcinoma.
Yoo EY; Nam SY; Choi HY; Hong MJ
Acta Radiol; 2018 Jan; 59(1):50-57. PubMed ID: 28425758
[TBL] [Abstract][Full Text] [Related]
7. Differences in morphological features and minimum apparent diffusion coefficient values among breast cancer subtypes using 3-tesla MRI.
Kato F; Kudo K; Yamashita H; Wang J; Hosoda M; Hatanaka KC; Mimura R; Oyama-Manabe N; Shirato H
Eur J Radiol; 2016 Jan; 85(1):96-102. PubMed ID: 26724653
[TBL] [Abstract][Full Text] [Related]
8. Quantitative MRI morphology of invasive breast cancer: correlation with immunohistochemical biomarkers and subtypes.
Bae MS; Seo M; Kim KG; Park IA; Moon WK
Acta Radiol; 2015 Mar; 56(3):269-75. PubMed ID: 24558165
[TBL] [Abstract][Full Text] [Related]
9. Correlation between imaging features and molecular subtypes of breast cancer in young women (≤30 years old).
Huang J; Lin Q; Cui C; Fei J; Su X; Li L; Ma J; Zhang M
Jpn J Radiol; 2020 Nov; 38(11):1062-1074. PubMed ID: 32562180
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017.
De Los Santos JF; Cantor A; Amos KD; Forero A; Golshan M; Horton JK; Hudis CA; Hylton NM; McGuire K; Meric-Bernstam F; Meszoely IM; Nanda R; Hwang ES
Cancer; 2013 May; 119(10):1776-83. PubMed ID: 23436342
[TBL] [Abstract][Full Text] [Related]
11. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MR imaging to assess response following neoadjuvant systemic treatment in various breast cancer subtypes: Comparison between different definitions of pathologic complete response.
Santamaría G; Bargalló X; Ganau S; Alonso I; Muñoz M; Mollà M; Fernández PL; Prat A
Eur J Radiol; 2019 Aug; 117():132-139. PubMed ID: 31307638
[TBL] [Abstract][Full Text] [Related]
13. Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner.
Panzironi G; Moffa G; Galati F; Marzocca F; Rizzo V; Pediconi F
Breast Cancer Res Treat; 2020 May; 181(1):53-60. PubMed ID: 32185587
[TBL] [Abstract][Full Text] [Related]
14. Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer?
Montemezzi S; Camera L; Giri MG; Pozzetto A; Caliò A; Meliadò G; Caumo F; Cavedon C
Eur J Radiol; 2018 Nov; 108():120-127. PubMed ID: 30396643
[TBL] [Abstract][Full Text] [Related]
15. Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis.
Surov A; Chang YW; Li L; Martincich L; Partridge SC; Kim JY; Wienke A
BMC Cancer; 2019 Nov; 19(1):1043. PubMed ID: 31690273
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging in breast cancer treated with neoadjuvant chemotherapy: radiologic-pathologic correlation of the response and disease-free survival depending on molecular subtype.
Cruz Ciria S; Jiménez Aragón F; García Mur C; Esteban Cuesta H; Gros Bañeres B
Radiologia; 2014; 56(6):524-32. PubMed ID: 23294850
[TBL] [Abstract][Full Text] [Related]
18. Machine learning with multiparametric breast MRI for prediction of Ki-67 and histologic grade in early-stage luminal breast cancer.
Song SE; Cho KR; Cho Y; Kim K; Jung SP; Seo BK; Woo OH
Eur Radiol; 2022 Feb; 32(2):853-863. PubMed ID: 34383145
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging.
Xie T; Zhao Q; Fu C; Bai Q; Zhou X; Li L; Grimm R; Liu L; Gu Y; Peng W
Eur Radiol; 2019 May; 29(5):2535-2544. PubMed ID: 30402704
[TBL] [Abstract][Full Text] [Related]
20. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes.
Youk JH; Son EJ; Chung J; Kim JA; Kim EK
Eur Radiol; 2012 Aug; 22(8):1724-34. PubMed ID: 22527371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]